SEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials
Portfolio Pulse from Jelena Martinovic
Cannabis Bioscience International Holdings (OTC: CBIH) has had its registration statement for the public offering of over 10 billion shares declared effective by the SEC. The company plans to use the proceeds to fund cannabis clinical trials using AI. Texas, where CBIH is based, maintains strict cannabis laws, but some cities are moving towards decriminalization. The article also promotes Benzinga PotProfits, highlighting recent gains in cannabis stocks and teasing upcoming stock picks.
December 15, 2023 | 3:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cannabis Bioscience International Holdings' shares are now publicly offered following SEC approval. The company aims to use the raised capital for AI-enhanced cannabis clinical trials, which could be a significant step in its growth and innovation in the cannabis sector.
The SEC's approval for CBIH's public offering is a positive development for the company, likely to attract investor attention and potentially raise significant capital for its clinical trials. The use of AI in these trials could set the company apart in the cannabis research field, which may positively impact the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100